Navigation Links
Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinson's Disease Hits Major Milestone
Date:9/30/2009

New molecules may be an alternative therapy for Parkinson's

NEW YORK, Sept. 30 /PRNewswire-USNewswire/ -- Michael J. Fox Foundation-funded researchers at Vanderbilt University Medical Center have reached a milestone in the development of potential new drugs for Parkinson's disease that may avoid the limitations of current therapy.

The team, which received an MJFF award of up to $4.4 million under the Foundation's 2007 LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) initiative, has identified two drug-like molecules that, when given systematically in a pre-clinical model of Parkinson's disease, reduce PD symptoms by acting on a specific glutamate receptor in the brain called the metabotropic glutamate receptor, or mGluR4.

Jeffrey Conn, PhD, director of the Vanderbilt Drug Discovery Program and leader of the research team, will detail the discovery in a presentation called "Discovery of mGluR4 Potentiators for Symptomatic and Disease-modifying Treatment of PD" at the third annual Parkinson's Disease Therapeutics Conference, hosted today in New York City by The Michael J. Fox Foundation and The New York Academy of Sciences.

"If we can develop a molecule that has the right properties and does not have toxicity, we really believe this has an opportunity to have a major impact for Parkinson's patients," said Conn. "Nothing could be more exciting than that... Nothing could be more satisfying."

"Obviously there are no guarantees," Dr. Conn cautioned. But if progress continues, clinical trials in patients with Parkinson's disease could begin sometime in 2013, he said.

In previous studies, Conn and others have found that they could relieve symptoms of Parkinson's disease in pre-clinical models by activating the mGluR4 receptor.

In their latest finding, the Vanderbilt researchers have found two compounds that act on mGluR4 and, when given systemically in a pre-clinica
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Michael J. Fox Foundation Commits Up to $12 Million for Targeted Parkinsons Therapeutic Development in 2010
2. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
3. Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinsons Therapeutic Targets
4. Michael J. Fox Foundation Commits up to $6.5 Million in Funding for Critical Challenges in Parkinsons Disease
5. Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinsons Disease
6. Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinsons Disease Clinical Trials
7. Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinsons Disease Research
8. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
9. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
10. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
11. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... YORK , July 3, 2015  Obsidian HDS, ... - an online service for the management of data ... announced today that PharmaShine now includes the 2014 Open ... for Medicare Services on June 30. The data disclosed ... million transactions between industry and providers totaling $6.49 billion ...
(Date:7/2/2015)... , July 2, 2015 Leading organizations ... capture critical product and market insights in internal ... to employee-based studies, it is essential for executives ... internal employees to capture critical business-related insights. ... firm, Best Practices, LLC, most benchmarked companies find ...
(Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
... success and expanded reimbursement coverageMINNEAPOLIS, Jan. 26 Uroplasty, ... completion of patient enrollment in the randomized, controlled multicenter ... the treatment of overactive bladder (OAB) symptoms of urinary ... A total of 214 patients have enrolled two months ...
... Patient Trial of 2nd Generation Oxazolidinone Enrolls in Four ... today announced the completion of enrollment in its randomized, ... form of torezolid (also known as TR-701) in patients ... The trial, which was conducted in 12 clinical sites ...
Cached Medicine Technology:Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 3Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 4Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... , ... July 03, 2015 , ... First Choice ... States, named Mariah N. Manzanares, MD as the new Medical Director of its Frisco ... medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... ... 02, 2015 , ... When Walker Parking Consultants specified Kenall ... Minnesota, they knew it would save the university energy and maintenance costs. What ... total energy savings after installation was an impressive 89 percent, which resulted in ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the ... hot temps, skin cancer is on the rise. July is UV Safety Month, and ... awareness about the importance of getting skin checks. Experts say most skin cancers can ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... Jan. 5 (HealthDay News) -- Women with multiple sclerosis are ... gene thought to be connected to the condition, a new ... more insight into the development of MS, which is becoming ... Although no one knows what causes MS, scientists suspect that ...
... Lou Gehrig,s disease, or amyotrophic lateral sclerosis (ALS), ... clumps in brain and spinal-cord cells that include an ... building block of the lesions formed by these clumps. ... Journal of Clinical Investigation , a team led by ...
... less expensive, more eco-friendly method for making deuterium-depleted drinking water, ... form of water. Their report appears in ACS, bi-weekly journal ... Meng and Feng Huang note that natural water, widely known ... amounts of D2O about 150 parts per million (ppm), ...
... Dr. Emil Kozarov and a team of researchers at ... specific bacteria that may have a key role in ... to as "hardening of the arteries" the number ... Fully understanding the role of infections in cardiovascular diseases ...
... control the maximum temperature of children,s bath water can ... should reduce the risk of scalding, according to researchers ... out in partnership with Glasgow Housing Association, found that ... the hot and cold water pipes in their bathroom ...
... simplified method for producing large amounts of viral vector ... help advance the promising field of gene therapy as ... trials. The novel adeno-associated virus (AAV) production method is ... publication in Human Gene Therapy , a peer-reviewed ...
Cached Medicine News:Health News:Study Sheds Light on Genetic Risk of MS 2Health News:Malfunctioning gene associated with Lou Gehrig's disease leads to nerve-cell death in mice 2Health News:Bacteria eyed for possible role in atherosclerosis 2Health News:Bacteria eyed for possible role in atherosclerosis 3Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 2Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 3Health News:Faster, scalable method for producing AAV-based gene transfer vectors 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: